Medtronic (MDT) Asset Writedowns and Impairment (2014 - 2026)

Medtronic has reported Asset Writedowns and Impairment for 13 years, with the latest figure at -$102.0 million in Q2 2026.

• Quarterly Asset Writedowns and Impairment fell 6.25% year-over-year to -$102.0 million in Q2 2026, while the trailing twelve-month figure through Jan 2026 was $6.0 million (down 98.52% YoY) and the FY2024 annual result came in at $371.0 million, changed N/A from the prior year.
• Asset Writedowns and Impairment declined to -$102.0 million in Q2 2026 per MDT's latest filing, from $36.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $466.0 million in Q2 2022 and troughed at -$466.0 million in Q1 2022.
• A 5-year average of $20.6 million and a median of $23.0 million in 2023 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment jumped 672.22% in 2024, then sank 131.07% in 2025.
• Over 5 years, Asset Writedowns and Impairment stood at $26.0 million in 2022, then slumped by 38.46% to $16.0 million in 2023, then jumped by 68.75% to $27.0 million in 2024, then jumped by 40.74% to $38.0 million in 2025, then plunged by 368.42% to -$102.0 million in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$102.0 million, $36.0 million, and $38.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.